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 Hepatic insulin resistance occurs in the setting of ele-
vated intracellular lipid content, with pathologic oxidative 
metabolism playing a likely, but poorly understood, role in 
this association ( 1–10 ). This ambiguity is highlighted by 
seemingly contradictory views of lipid oxidation during 
hepatic insulin resistance. One view emerged from the dis-
covery that small molecule byproducts of impaired or 
incomplete lipid catabolism (diacylglycerol, ceramides, 
acyl-CoA) antagonize insulin action via protein kinase-C 
(PKC)-dependent phosphorylation of the insulin receptor 
substrate (IRS) in skeletal muscle ( 1–4 ). Impaired lipid 
oxidation has also been proposed in the insulin-resistant 
liver, providing a plausible mechanism for the strong as-
sociation between hepatic insulin resistance and nonalco-
holic fatty liver disease (NALFD) ( 2, 3, 6, 7 ). However, a 
second view, developed mainly in the context of NAFLD, 
posits that elevated lipid burden stimulates hepatic fat oxi-
dation and results in excessive formation of reactive oxy-
gen species (ROS) ( 5, 8–10 ). The resulting oxidative stress 
and organelle damage may play a critical role in the pro-
gression from benign NAFLD to infl ammatory nonalco-
holic steatohepatitis (NASH) and cirrhosis ( 10, 11 ). In the 
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gluconeogenesis, and modifi ed versions of these pathways 
are also required for lipogenesis and amino acid metabo-
lism ( 32 ). Anaplerosis/cataplerosis is a substantial pathway 
in liver, roughly 3- to 5-fold more active than oxidative 
TCA cycle fl ux ( 36 ). Thus, the hepatic TCA cycle is semi-
autonomous of   -oxidation and intimately linked to bio-
synthesis and cellular respiration, but its function during 
insulin resistance is unknown. 
 Given the putative link between insulin resistance, ele-
vated gluconeogenesis, and loss of mitochondrial respira-
tory integrity, we hypothesized that impaired insulin 
signaling should result in increased oxidative and anaple-
rotic/cataplerotic fl uxes of the TCA cycle. Hepatic metab-
olism was examined in mice after 8, 16, and 32 weeks of a 
HFD using standard biomolecular methods and  2 H/ 13 C 
tracers of hepatic metabolism. Hepatic mitochondrial 
content, respiration, metabolomic markers of   -oxidation, 
and in vivo metabolic fl ux in TCA cycle pathways were el-
evated with loss of hepatic insulin action. Mitochondrial 
uncoupling, oxidative stress, and infl ammation developed 
synchronously with the induction of oxidative TCA cycle 
fl ux. The fi ndings indicate that loss of hepatic insulin ac-
tion induces TCA cycle fl ux, which in the setting of im-
paired respiratory effi ciency may contribute to oxidative 
stress and ultimately infl ammation. 
 MATERIALS AND METHODS 
 Animals and diets 
 Animal protocols were approved by the Institutional Animal 
Care and Use Committee at the University of Texas Southwestern 
Medical Center. Four- to six-week-old male C57Bl/6 mice 
(Charles River) were fed either a control semisynthetic diet (10% 
fat calories; Teklad diet TD06416; Harlan Laboratories) or a 
high-fat diet (60% fat calories; Teklad diet TD06414; Harlan Lab-
oratories) for 8, 16, or 32 weeks to induce obesity and insulin re-
sistance. Experiments were carried out after an overnight fast 
(  16 h) unless otherwise noted. 
 Stable isotope tracer infusions 
 Mice were surgically implanted with indwelling jugular vein 
catheters and allowed to recover for fi ve days. Following an over-
night fast, unrestrained mice were infused with [3,4- 13 C 2 ]acetoac-
etate and [U- 13 C 4 ]sodium   -hydroxybutyrate as a bolus (8.8 and 
6.7 µmol/hr) for 10 min and as a continuous infusion (3.5 and 
2.7 µmol/hr) for a further 80 min ( 26 ). At the end of 90 min, 
approximately 50 µl of blood was collected for LC-MS/MS analy-
sis of ketone turnover ( 26 ). Mice then received an intraperito-
neal injection of isotonic D 2 O (99%; 28 µl/ body weight) and 
administration of [U- 13 C 3 ]propionate (50 mg/ml) and [3,4- 
13 C 2 ]
glucose (3.72 mg/ml) as a bolus (6.1 µmol/hr) for the fi rst 10 
min and continuous (1.2 µmol/hr) for the next 80 min. After 
mice were anesthetized, whole blood was collected from the de-
scending aorta, and tissues were collected and stored at   80°C 
until further analysis. 
 LC-MS/MS analysis of ketone tracer dilution 
 Thawed blood was immediately spiked with an equal volume 
of 1M NaB 2 H 4 to convert labile acetoacetate (ACAC) to stabile 
  -hydroxybutyrate (BHB), with the deuterium tag (M+1), preserv-
ing its source as acetoacetate ( 37 ). Samples were purifi ed by ion 
context of hepatic insulin resistance, excessive oxidative 
metabolism is suffi cient to activate infl ammatory pathways, 
which further disrupt insulin action ( 5, 9, 12–16 ). 
 Despite disagreement regarding the link between he-
patic insulin resistance, lipid oxidation, and fatty liver, mi-
tochondrial respiratory dysfunction is a common corollary 
in most models of chronic hepatic insulin resistance. Indi-
viduals with NASH have hepatic mitochondria with ultra-
structural and respiratory chain damage ( 8, 17 ), and 
high-fat diet (HFD) mice have mitochondria with reduced 
respiratory effi ciency, which promotes ROS-mediated he-
patocellular damage ( 18 ). In humans, poorly coupled res-
piration is recapitulated as impaired hepatic ATP turnover 
during NASH and diabetes ( 19, 20 ). The development of 
respiratory dysfunction and ROS production has been di-
rectly linked to impaired hepatic insulin action via fork-
head transcription factor 1 (Foxo1) activity, which results 
not only in upregulation of gluconeogenic and oxidative 
genes ( 21 ) but also in heme-catabolizing enzymes that 
damage respiratory complexes ( 22, 23 ). However, even a 
clear role for respiratory dysfunction does little to clarify 
oxidative function in the insulin-resistant liver. Impaired 
insulin action predicts elevated oxidative metabolism (via 
PGC-1  , for example) ( 21 ), and uncoupled respiration 
should theoretically increase oxidative metabolism. Sev-
eral ex vivo studies of mitochondria from HFD mice con-
fi rm elevated respiration ( 24–27 ), which may increase 
oxygen consumption and predispose liver to hypoxia ( 18 ). 
However, other studies implicate respiratory dysfunction 
in the deactivation of surtuins and PGC-1  , which in turn 
suppress hepatic fat oxidation and cause hepatic steatosis 
( 22, 23, 28, 29 ). Unfortunately, most conclusions have 
been based on ex vivo mitochondrial respiration or fat oxi-
dation, leaving the physiologic function of hepatic oxida-
tive metabolism during insulin resistance unclear. 
 The tricarboxylic acid (TCA) cycle links fat oxidation to 
respiration by converting acetyl-CoA to CO 2 and harvest-
ing electrons as 3NADH and a FADH 2 for respiratory com-
plexes 1 and 2, respectively. The activity of TCA cycle 
oxidation is acutely regulated by cellular energy charge 
and redox state, which precisely matches NADH produc-
tion to respiratory demand ( 30, 31 ). A unique feature of 
liver mitochondria is that the hepatic TCA cycle is not req-
uisitely yoked to   -oxidation because acetyl-CoA in excess 
of cellular energy demand is shunted to ketogenesis. Thus, 
the TCA cycle remains matched to cellular respiratory de-
mand, whereas ketogenesis dissipates excess acetyl-CoA 
into ketones for peripheral oxidation, while also reducing 
the gluconeogenic burden of the liver ( 30, 31 ). Another 
specialized feature of the hepatocellular TCA cycle is that 
it harbors prominent anaplerotic and cataplerotic (non-
oxidative) pathways required for gluconeogenesis, lipo-
genesis, and ureagenesis ( 32 ). These pathways are 
upregulated by insulin resistance ( 33–35 ), but their func-
tions are rarely recapitulated during ex vivo examination 
of mitochondrial oxidative/respiratory metabolism. Pyru-
vate carboxylase (PC) and phosphoenolpyruvate (PEP) 
carboxykinase (PEPCK) are the archetypal anaplerotic 
and cataplerotic enzymes of liver that are required for 
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  GNG from glycerol v3/v1   (H5 H6s) / H2  (Eq. 3) 
  GNG from PEP v4/v1   H6s / H2  (Eq. 4) 
 Relative rates of the TCA cycle 
 First-pass metabolism of propionate occurs almost exclusively 
in liver of rodents ( 45 ), where it is carboxylated and converted to 
the TCA cycle intermediate succinyl-CoA. Carbon isotope tracers 
of propionate have been used to assess relative rates of the he-
patic TCA cycle in humans ( 46, 47 ) and rodents ( 39–41 ). Car-
bon-13 isotopomers of glucose formed by tracer level TCA cycle 
metabolism of [U- 13 C]propionate were quantifi ed by  13 C NMR 
analysis of the C2 resonance of MAG ( 48 ), which provided the 
relative abundance of three isotopomers of glucose: [1,2- 13 C]glu-
cose, [2,3- 13 C]glucose, and [1,2,3- 13 C]glucose, corresponding to 
the D12, D23, and Q signals of a nine-line multiplet. Isotopomer 
data were evaluated using a model similar to Magnusson and 
Landau ( 36 ), but it was generated by an independent set of dif-
ferential equations ( 49 ) to determine fl uxes of the TCA cycle. 
Inasmuch as acetyl-CoA and bicarbonate used in the TCA cycle 
are not labeled, these differential equations reduce to three sim-
ple equations ( 41, 48 ) for fl ux through pathways relative to oxi-
dative TCA cycle fl ux (v7) (in triose units). 
 Pyruvate cycling /TCA cycle v5/v7   (D12 Q) / D23  
(Eq. 5) 
 Anaplerosis/TCA cycle v6/v7   (D12 D23) / D23   (Eq. 6) 
  GNG /TCA cycle v4/v7   (Q D23) / D23  (Eq. 7) 
 Absolute rates of metabolic fl ux 
 See supplemental material for more details. Briefl y,  equations 
1–7 were solved for seven fl uxes (v1–v7) as we previously de-
scribed ( 41 ) and as presented in supplementary Table VII. Nor-
malization of the equations assumes that  2 H and  13 C isotopomers 
of glucose have common origins in the liver ( 41 ). 
 Palmitate oxidation in liver homogenates 
 Oxidation of palmitate in the liver of 24 h fasted animals was per-
formed as described by Dohm et al. ( 50 ) with few modifi cations. 
Briefl y,   500 mg of liver in 2.5 ml of reaction buffer (2 mM ATP, 
0.05 mM CoA, 1 mM dithiotreitol, 0.1 mM NAD + , 1 mM DL-carni-
tine, 0.1 mM malate, 1 mM MgCl 2 , 0.072 mM fatty acid free BSA, 
100 mM sucrose, 10 mM K 2 HPO 4 , 80 mM KCl, 0.1 mM EDTA, 
100 mM HEPES pH 7.3) was homogenized in a hand-operated 
Potter-Elvehjem homogenizer by 15 strokes. Reaction was started by 
adding 3   l of [1- 14 C] palmitate (0.3 mCi, fi nal 25 mM; PerkinEl-
mer) to 200   l of homogenate and incubated at 37°C for 4, 5, 6, and 
7 min. Palmitate oxidation was terminated by injecting 100   l of 7% 
HClO 4 followed by centrifugation at 15,000  g for 10 min. Then 
200   l of supernatant was counted for incorporation of  14 C into acid 
soluble molecules in 6 ml of scintillation liquid. After conversion to 
DPM, oxidation rate was calculated as nanomoles of palmitate per 
minute per milligram of tissue and then per whole liver . 
 Hepatic insulin resistance 
 Progression of hepatic insulin resistance on a high-fat diet was 
evaluated using the Matsuda index ( 51 ). Further qualification 
of insulin’s ability to suppress hepatic ketogenesis was assessed 
by hyperinsulinemic-euglycemic clamp as we previously de-
scribed ( 52 ) but modified to include [3,4- 13 C 2 ]acetoacetate 
and [U- 13 C 4 ]  -hydroxybutyrate. Briefl y, mice were acclimated to 
a tube holder by daily exposure for 6–8 days prior to the clamp. 
An initial 90 min of ketone tracer infusion, as described above, 
exchange chromatography and analyzed on a API 3200 triple 
quadrupole LC-MS/MS (Applied Biosystems/Sciex Instruments) 
under positive ionization to determine enrichments of   -hydoxy-
butyrate mass isotopomers ( 26 ). The following MRM transitions 
were monitored to quantify   -hydroxybutyrate isotopomers. These 
data were fi t to a two-pool model of ketone turnover ( 38 ). 
 Detection of   -hydroxybutyrate originating from: 
  -hydroxybutyrate 105/87 (M+0) 
 Reduced acetoacetate 106/88 (M+1) 
 [3,4- 13 C]  -hydroxybutyrate 107/89 (M+2) 
 Reduced [3,4- 13 C]acetoacetate 108/90 (M+3) 
 [1,2,3,4- 13 C]  -hydroxybutyrate 109/91 (M+4) 
 Reduced [1,2,3,4- 13 C]acetoacetate 110/92 (M+5) 
 Assumptions, limitations and validation of apparent ketone 
turnover as an indicator of ketogenesis have been evaluated by us 
( 26, 39 ) and others ( 37, 38 ). Briefl y, this methodology hinges on 
the assumption that ketone tracers are only diluted by ketone 
production by liver or exchange between   -hydroxybutyrate and 
acetoacetate. There appears to be an unknown degree of dilu-
tion by extrahepatic tissues, termed pseudoketogenesis, which 
cannot be quantifi ed by tracer methodology ( 37 ), but it appears 
to be small as A/V differences agree with tracer dilution ( 38 ). In 
rodents, we found ketone turnover to be very sensitive to nutri-
tional, pharmacologic, and genetic manipulation of hepatic fat 
oxidation ( 26, 39 ). 
 Isotopomer analysis by NMR 
 Whole blood (  0.75 ml) was deproteinized with equal vol-
umes of 0.3N zinc sulfate and 0.3N barium hydroxide and lyo-
philized. Blood glucose was converted to 1,2-isopropylidene 
glucofuranose (monoacetone glucose, MAG) ( 40, 41 ). MAG was 
analyzed by  2 H and  13 C NMR on a 14T NMR INOVA spectrome-
ter with a 3 mm broadband probe (Varian, Palo Alto, CA), and 
peak areas were integrated using the 1D NMR software ACD/
Labs 11.0 (Advanced Chemistry Development, Toronto, Ontario, 
Canada) as previously described ( 40, 41 ). 
 Endogenous glucose production 
 Steady state infusion of [3,4- 13 C 2 ]glucose was used to deter-
mine endogenous glucose production (EGP) using the tracer 
dilution approach ( 40–42 ). Briefl y, [3,4- 13 C 2 ]glucose was de-
tected as the C3 D34 signal and the C4 D43 signal. These signals 
were averaged and compared with a standard curve to determine 
absolute plasma [3,4- 13 C 2 ]glucose enrichment . 
  
EGP v1   infusate enrichment
plasma glucose enrichment
/ plasma glucose enrichment
/tracer infusion rate
  (Eq. 1) 
 Relative gluconeogenesis 
 The fractional contribution of glycogenolysis (GLY), total glu-
coneogenesis (GNG), and TCA cycle gluconeogenesis (i.e., via 
phosphoenolpyruvate) to endogenous glucose production were 
determined from the relative deuterium enrichments in the H2, 
H5, and H6s position of MAG ( 43 ) as determined by  2 H NMR 
analysis ( 44 ). Briefl y, H2 enrichment occurs during any source of 
glucose production (glycogenolysis, gluconeogenesis from glyc-
erol, gluconeogenesis from TCA cycle substrates); H5 enrich-
ment occurs during the triose isomerase reaction during any 
source of gluconeogenesis; H6s enrichment occurs during gluco-
neogenesis from TCA cycle substrates ( 43 ). Thus fl uxes relative 
to EGP (in hexose units) are : 
  GLY   v2/v1   1 H5 / H2   (Eq. 2) 
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 Hepatic mitochondrial DNA content 
 Total DNA was isolated from the liver using phenol/chloro-
form/isoamylalcohol (25:4:1) extraction and ethanol precipita-
tion. Quantitative real-time PCR was performed in triplicate 
using SYBR GreenER™ qPCR SuperMix for ABI PRISM ® Instru-
ment (Invitrogen), primers for mitochondrial  mt-Nd2 and nu-
clear  Ndufv1 , and ABI PRISM 7900HT Fast Real-Time PCR System 
(Applied Biosystems). Relative DNA content was quantifi ed from 
Ct values using decimal dilutions of one of the samples as stan-
dard curve. Mitochondrial DNA (mtDNA) content is expressed 
per diploid nucleus. 
 Histology 
 Liver from overnight-fasted mice were fi xed in methanol-free 
4% paraformaldehyde for 20–24 h, cryoprotected with sequential 
10% and 18% sucrose equilibrations for 12 h at 4°C, and then 
cryoembedded in optimal cutting temperature medium (OCT; 
Sakura Finetek, Torrence, CA). Multiple plane 8 µm thick cryostat 
sections were prepared and temporarily stored at   80°C. Staining 
for lipids was conducted using saturated 0.18% Oil Red O (Sigma-
Aldrich, St. Louis, MO) prepared in 60% isopropyl alcohol accord-
ing to established histology protocol. The slides were counterstained 
with Hematoxylin and cover slips applied using aqueous mount-
ing medium (Vector Laboratories, Inc., Burlingame, CA). 
 Infl ammatory markers 
 Plasma infl ammatory cytokine analysis was performed by the 
University of Texas Southwestern Metabolic Core using Luminex 
100 bead mapping technology (Luminex, Austin, TX). 
 Biochemical measurements 
 Blood glucose concentration was measured with a glucometer 
(Accuchek; Roche Diagnostics, IN). Analytical kits were used to 
determine liver triglycerides (Sigma-Aldrich, St. Louis, MO), 
plasma free fatty acids (Wako Chemicals Inc., Richmond, VA), 
total ketones (Wako Chemicals Inc.), lipid peroxidation in fro-
zen liver homogenates (Cayman Chemical Co., MI) and antioxi-
dant activity of superoxide dismutase (Cayman Chemical Co.). 
Enzyme-linked immunoassays were used to measure plasma insu-
lin (ALPCO Diagnostics, NH), adiponectin (Millipore Corpora-
tion, MA), and leptin (Crystal Chem Inc., IL). 
 Materials 
 [3, 4- 13 C]glucose (98%) was purchased from Omicron Bio-
chemicals (South Bend, IN). [3, 4- 13 C 2 ]ethylacetoacetate (98%) 
and [U-  13 C 4 ]  -hydroxybutyrate (98%) were purchased from Iso-
tec (St. Louis, MO). [U- 13 C]propionate and deuterium oxide 
(99%) were purchased from Cambridge Isotopes (Andover, 
MA). Other common chemicals were obtained from Sigma (St. 
Louis, MO). 
 Statistical analysis 
 All data are presented as the mean ± SE. Differences between 
groups were analyzed using ANOVA, and pairwise mean com-
parisons were done using an unpaired  t -test. Differences were 
considered signifi cant at  P   0.05. 
 RESULTS 
 HFD results in obesity insulin resistance, hyperglycemia, 
and fatty liver 
 The metabolic characteristics of fasted mice maintained 
on a HFD for up to 32 weeks are presented in  Table 1 .  HFD 
mice had increased body weights at 8 (+30%), 16 (+34%), 
was performed to determine basal fasting ketone turnover. Mice 
were restrained in a tube holder and insulin (10 mU/kg/min) 
and ketone tracers were infused at a constant rate. Blood glucose 
levels were monitored from the tail vein every 10 minutes, and 
euglycemia was maintained by variable infusion of 30% glucose. 
After 80 min of hyperinsulinemic euglycemia, steady-state blood 
ketone enrichments were determined by LC-MS/MS as described 
above. 
 LC-MS/MS analysis of liver acylcarnitines and ceramides 
 Acylcarnitines and ceramides were measured on an API 3200 
triple quadrapole LC-MS/MS as previously described ( 53, 54 ). 
Briefl y, free carnitine and acylcarnitines were extracted from the 
liver and derivatized, and then individual acylcarnitine peaks 
were quantifi ed by comparison with a  13 C internal standard 
(Cambridge Isotopes, Andover, MA) ( 53 ). Liver ceramides were 
extracted by chloroform/methanol extraction and ceramide 
peaks were quantifi ed by comparison with a  13 C internal standard 
(Cambridge Isotopes) ( 54 ). Metabolites were normalized to the 
liver protein (Thermo Scientifi c, Rockford, IL). 
 Hepatic mitochondrial respiration 
 Crude mitochondria were isolated from the livers of overnight-
fasted mice as described previously ( 55 ). Mitochondrial loading 
was estimated from protein content determined from a Bradford 
assay. Respiration rates were determined at 37°C in 1 ml of reac-
tion buffer (100 mM KCl, 20 mM sucrose, 10 mM KH2PO4, 
5 mM HEPES, 2 mM MgCl2-6H2O, 1 mM EGTA, pH 7.2, and 0.5% 
BSA) using a Clark-type O 2 electrode (Oxygraph Oxygen elec-
trode; Hansatech Instruments, Norfolk, England) with either 
succinate (2.5 mM), glutamate/malate (5 mM/2.5 mM), or 
palmitoyl-L-carnitine/malate (20 µM/2.5 mM) as substrates. 
When using succinate, complex I was inhibited with rotenone 
(2 µM). State 2 (basal, leak) respiration was measured after addition 
of 0.66 mg of mitochondria and respiratory substrate, state 3 res-
piration was induced by adding ADP (150 µM), and state 4 respi-
ration was measured after ADP depletion. Respiratory control 
ratio (RCR) was calculated as the ratio of state 3 to state 4 respira-
tions. P/O ratio was calculated as the ratio of ATP formed to oxy-
gen consumed. Respiration rates were normalized to citrate 
synthase activity (Citrate Synthase Assay kit; Sigma-Aldrich, St. 
Louis, MO). 
 Gene expression analysis 
 Total RNA was extracted from tissues with RNA Stat-60 reagent 
(Tel-Test, Friendswood, TX). cDNA was synthesized from 4 µg of 
RNA treated with 0.2 U DNase (Qaigen, Valencia, CA) using 
High Capacity cDNA Reverse Transcription Kit (Applied Biosys-
tems, Carlsbad, CA). Quantitative real-time PCR was run in tripli-
cates using SYBR GreenER™ qPCR SuperMix for ABI PRISM ® 
instrument (Invitrogen, Carlsbad, CA) and ABI PRISM 7900HT 
Fast Real-Time PCR System (Applied Biosystems). Gene expres-
sion was normalized to cyclophilin b (Ppib). Primer sequences 
will be provided upon request. 
 Western blot analysis 
 Frozen livers or crude mitochondria were homogenized in 
RIPA buffer (Cell Signaling Technology, Danvers, MA) with com-
plete protease inhibitors (Roche Diagnostics, Indianapolis, IN). 
Proteins were separated with SDS-PAGE and transferred onto a 
Protran TM nitrocellulose membrane (Whatman/GE Healthcare, 
Piscataway, NJ) or Immobilon-P PVDF membrane (Millipore, Bil-
lerica, MA). Primary antibodies were obtained from Cell Signal-
ing. Mitochondrial carbonylated proteins were assessed using 
OxiSelect TM Protein Carbonyl Immunoblot Kit (Cell Biolabs, San 
Diego, CA). 
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( Table 1 ). The duration of HFD was associated with in-
creased hepatic steatosis indicated by elevated liver triglyc-
eride content ( Table 1 ) and positive Oil Red O staining 
( Fig. 1A ).  Increasing hepatic lipid content and the dura-
tion of HFD was also associated with a decline in hepatic 
and 32 (+38%) weeks. Body composition analysis by mag-
netic resonance indicated that excess body weight was 
composed mainly of increased adiposity ( Table 1 ). The de-
velopment of obesity was accompanied by progressing 
hyperinsulinemia, hyperleptinemia, and hyperglycemia 
 TABLE 1. Metabolic characteristics of overnight-fasted mice on a high-fat diet 
8 Weeks 16 Weeks 32 Weeks
Control Diet HFD Control Diet HFD Control Diet HFD
Body weight (g) 29.3 ± 0.7 38.2 ± 1.5 a 31.5 ± 1.4 42.4 ± 1.3 a 38.5 ± 0.7 53.6 ± 1.8 a 
Lean body weight (%) 61.6 ± 0.7 50.0 ± 0.9 a 56.7 ± 1.4 49.2 ± 1.4 a 53.2 ± 0.4 45.5 ± 1.9 a 
Body fat (%) 26.0 ± 1.1 42.9 ± 0.70 a 33.6 ± 1.6 44.3 ± 1.5 a 37.1 ± 0.3 48.6 ± 2.1 a 
Liver TG (mg/g liver) 81 ± 10 110 ± 12 a 94.1 ± 25 159 ± 22 a 132 ± 7 189 ± 25 a 
Glucose (mg/dl) 67.7 ± 2.2 102 ± 6.9 a 72.5 ± 2.7 116 ± 11 a 87.7 ± 2.0 135 ± 11 a 
Insulin (ng/ml) 0.41 ± 0.03 1.92 ± 0.32 a 0.18 ± 0.02 2.2 ± 0.2 a 0.43 ± 0.05 5.2 ± 0.8 a 
NEFA (µEQ/l) 586 ± 36 697 ± 67 876 ± 82 1129 ± 100 a 610 ± 71 535 ± 78
Ketone (µmol/l) 1220 ± 104 1179 ± 119 719 ± 126 1189 ± 161 a 1263 ± 174 789 ± 141 a 
Leptin (ng/ml) 13.2 ± 1.3 83.3 ± 11 a 45.1 ± 3.5 105 ± 11 a 33.9 ± 5.5 119 ± 12 a 
Adiponectin (ng/ml) 4297 ± 164 3667 ± 132 a 3866 ± 72.0 3914 ± 113 3858 ± 86.0 4034 ± 150
Data are represented as the mean ± SE (n = 6–8).
 a P   0.05 between control and high-fat groups.
 Fig.  1. HFD mice have fatty liver with impaired insulin action. (A) Oil red O-stained liver sections (original 
magnifi cation ×10; n = 2); (B) hepatic insulin sensitivity index; (C) insulin-stimulated phosphorylation of 
Akt T308 and Akt S473 ; (D) insulin-stimulated Foxo1 phosphorylation; (E) endogenous glucose production; (F) 
total gluconeogenesis; and (G) hepatic anaplerosis or pyruvate carboxylase fl ux in overnight-fasted mice fed 
either a control or a high-fat diet for 8, 16, and 32 weeks. Data are presented as the mean ± SE (n = 6–8). 
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after 8 wks but decreased with longer durations of HFD 
( Fig. 1D ). Gene expression analysis ( Table 2 )  indicated 
increased expression of G6Pase after 16 weeks; however, 
PC and PEPCK were not different or slightly decreased. 
We further confi rmed these fi ndings by Western blotting, 
which revealed a slight decrease in PEPCK protein (not 
shown). These data are consistent with other fi ndings in 
HFD rodents and humans with type 2 diabetes, which did 
not have elevated hepatic PEPCK ( 57 ). Thus, we carefully 
examined gluconeogenic function by measuring glucose 
turnover (supplementary Table I and  Fig. 1E ) with simul-
taneous administration of  2 H 2 O. Relative deuterium en-
richments of glucose H2, H5, and H6s were determined by 
 2 H NMR (supplementary Table II), and these data were 
used to evaluate the fractional contributions of glycog-
enolysis, gluconeogenesis from glycerol, and gluconeogene-
sis from TCA cycle cataplerosis to glucose production 
(supplementary Table III). Fractional contributions were 
unremarkable, with the exception of 32-week HFD mice, 
which had an elevated contribution from glycogenolysis. 
However, consistent with reduced Foxo1 phosphoryla-
tion, fasting endogenous glucose production and total 
insulin sensitivity ( Fig. 1B ) and blunted hepatic Akt phos-
phorylation during an insulin challenge ( Fig. 1C and 
supplementary Fig. I-C). However, we noted that Akt phos-
phorylation was either not different or slightly increased 
in the absence of an insulin challenge (supplementary Fig. 
I-A, B). These data confi rm that mice fed a HFD in this 
study exhibited progressing hepatic steatosis and insulin 
resistance; therefore, they were used to assess the mito-
chondrial TCA cycle during this process. 
 Mitochondrial TCA cycle anaplerosis and 
gluconeogenesis are increased in the liver of HFD mice 
 Anaplerosis, which refers to the conversion of cytosolic 
metabolites into mitochondrial TCA cycle intermediates, 
is a critical pathway for gluconeogenesis and other biosyn-
thetic processes ( 32 ). In liver, anaplerosis is governed by 
mitochondrial PC, an enzyme that converts pyruvate to ox-
aloacetate and controls the rate of cataplerotic PEPCK 
fl ux for gluconeogenesis ( 56 ). Because insulin action reg-
ulates this process, we evaluated gluconeogenesis and the 
upstream pathways of mitochondrial anaplerosis and cata-
plerosis during HFD. Foxo1 phosphorylation was normal 
 TABLE 2. Expressions of genes related to carbohydrate, lipid, and mitochondrial metabolism in liver of 
overnight-fasted mice on a high-fat diet 
8 Weeks 16 Weeks 32 Weeks
Control Diet HFD Control Diet HFD Control Diet HFD
Glucose production
 Pck1 1.0 ± 0.16 0.6 ± 0.13 1.0 ± 0.10 0.9 ± 0.12 1.0 ± 0.10 0.6 ± 0.07 a 
 Pc 1.0 ± 0.17 0.8 ± 0.12 1.0 ± 0.09 1.0 ± 0.10 1.0 ± 0.09 0.6 ± 0.07 a 
 G6pase 1.0 ± 0.32 0.9 ± 0.16 1.0 ± 0.19 3.2 ± 0.50 a 1.0 ± 0.26 1.8 ± 0.52 a 
 Mdh1 1.0 ± 0.18 0.6 ± 0.09 a 1.0 ± 0.08 0.7 ± 0.15 a 1.0 ± 0.07 0.6 ± 0.07 a 
 Foxo1 1.0 ± 0.15 1.0 ± 0.20 1.0 ± 0.09 1.1 ± 0.20 1.0 ± 0.14 1.0 ± 0.09
Glucose transport
 Glut2/ Slc2a2 1.0 ± 0.17 1.1 ± 0.18 1.0 ± 0.11 1.1 ± 0.15 1.0 ± 0.09 0.6 ± 0.07 a 
Fat oxidation and ketogenesis
 Pgc1a/Ppargc1a 1.0 ± 0.17 1.1 ± 0.20 1.0 ± 0.28 1.5 ± 0.27 a 1.0 ± 0.13 1.1 ± 0.16
 Ppara 1.0 ± 0.09 1.2 ± 0.19 1.0 ± 0.15 1.2 ± 0.24 1.0 ± 0.18 0.5 ± 0.08 a 
 Cpt1a 1.0 ± 0.18 1.2 ± 0.16 1.0 ± 0.18 1.2 ± 0.21 1.0 ± 0.13 0.5 ± 0.07 a 
 Vlcad/Acadvl 1.0 ± 0.13 1.2 ± 0.15 1.0 ± 0.10 0.9 ± 0.17 1.0 ± 0.11 0.9 ± 0.26
 Lcad/Acadl 1.0 ± 0.14 1.0 ± 0.13 1.0 ± 0.14 1.0 ± 0.19 1.0 ± 0.15 0.8 ± 0.28
 Mcad/Acadm 1.0 ± 0.13 1.3 ± 0.17 1.0 ± 0.11 1.0 ± 0.17 1.0 ± 0.13 1.1 ± 0.16
 Cd36/Fat 1.0 ± 0.05 1.0 ± 0.08 1.0 ± 0.13 1.9 ± 0.26 1.0 ± 0.10 0.9 ± 0.10
 Hmgcs2 1.0 ± 0.14 0.8 ± 0.07 1.0 ± 0.04 0.8 ± 0.16 1.0 ± 0.07 0.5 ± 0.09 a 
 Acc2/Acacb 1.0 ± 0.13 0.8 ± 0.12 1.0 ± 0.21 1.1 ± 0.20 1.0 ± 0.20 2.6 ± 0.33 a 
Kreb’s cycle
 Cs 1.0 ± 0.18 0.7 ± 0.14 1.0 ± 0.14 1.1 ± 0.15 1.0 ± 0.13 0.9 ± 0.12
Mitochondrial respiration
 Cycs 1.0 ± 0.34 0.7 ± 0.07 1.0 ± 0.06 1.04 ± 0.079 1.0 ± 0.14 1.1 ± 0.20
 Cox4i1 1.0 ± 0.25 0.9 ± 0.15 1.0 ± 0.13 0.8 ± 0.09 1.0 ± 0.14 1.3 ± 0.18
 Ucp2 1.0 ± 0.29 1.1 ± 0.15 1.0 ± 0.19 2.6 ± 0.61 a 1.0 ± 0.08 2.1 ± 0.65 b 
Lipogenesis
 Lxr  /Nr1 h3 1.0 ± 0.06 0.9 ± 0.12 1.0 ± 0.12 0.8 ± 0.12 1.0 ± 0.10 1.6 ± 0.12 a 
 Srebp1c/Srebf1 1.0 ± 0.15 1.4 ± 0.19 1.0 ± 0.08 1.9 ± 0.65 a 1.0 ± 0.11 2.0 ± 0.23 a 
 Fasn 1.0 ± 0.11 0.8 ± 0.08 1.0 ± 0.10 1.1 ± 0.15 1.0 ± 0.18 1.0 ± 0.10
 Chrebp/Mlxipl 1.0 ± 0.05 0.7 ± 0.10 a 1.0 ± 0.11 0.7 ± 0.11 a 1.0 ± 0.14 0.4 ± 0.04 a 
 Hmgcr 1.0 ± 0.20 1.0 ± 0.17 1.0 ± 0.11 1.1 ± 0.16 1.0 ± 0.12 0.8 ± 0.12
 Hmgcs1 1.0 ± 0.08 1.9 ± 0.15 a 1.0 ± 0.11 2.2 ± 0.37 a 1.0 ± 0.10 1.0 ± 0.19
 Acc1/Acaca 1.0 ± 0.18 0.9 ± 0.16 1.0 ± 0.09 0.9 ± 0.09 1.0 ± 0.09 0.9 ± 0.10
Glycolysis
 Gck 1.0 ± 0.23 0.6 ± 0.11 1.0 ± 0.09 1.6 ± 0.18 a 1.0 ± 0.09 1.4 ± 0.21 a 
Pentose phosphate pathway
 G6pdx 1.0 ± 0.17 1.0 ± 0.17 1.0 ± 0.10 1.1 ± 0.17 1.0 ± 0.12 1.0 ± 0.13
Data are represented as the mean ± SE (n = 5).
 a P   0.05 between control and high-fat groups.
 b P   0.1 between control and high-fat groups.
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Taken together, metabolomic analysis, in vivo isotopomer 
analysis, and ex vivo radio-tracer analysis demonstrated 
that hepatic oxidative metabolism was elevated in the insu-
lin-resistant and fatty liver after 16–32 weeks of HFD. 
 Mitochondrial ketogenesis is constitutively active, but 
blunted, by severe insulin resistance 
 During fasting,   -oxidation exceeds hepatic respiratory 
requirements, and the resulting acetyl-CoA in excess of 
TCA cycle oxidative demand is dissipated into ketogenesis 
( 31 ). Thus, we examined ketogenesis throughout 32 weeks 
of a HFD to evaluate overall hepatic   -oxidation in the set-
ting of elevated TCA cycle fl ux during insulin resistance. 
Fasting plasma ketone concentration became elevated 
after 16 weeks (+65%,  P  = 0.01), but it fell below normal 
after 32 weeks of HFD (  38%,  P  = 0.03) ( Table 1 ). Like-
wise, apparent ketone turnover was higher after 16 weeks 
( P  = 0.05) but slightly lower after 32 weeks of HFD ( P  = 
0.02) ( Fig. 2D ). These data were consistent with ex vivo 
rates of palmitate oxidation ( Fig. 2C ) and the induction of 
hepatic  Pgc1  after 16 weeks, followed by the downregula-
tion of  Ppar  ,  Cpt1a , and  Hmgcs2 after 32 weeks ( Table 2 ). 
Thus, in agreement with our previous fi ndings ( 26, 39 ), 
fasting ketone turnover is increased with moderate insulin 
resistance but is impaired by severe insulin resistance. 
 Blunted fasting ketogenesis after 32 weeks of HFD con-
trasted with elevated oxidative TCA cycle fl ux, so we fur-
ther tested whether this pathway was appropriately 
regulated by nutritional state and insulin action. Control 
mice suppressed fasting ketogenesis by 40-fold during a 
hyperinsulinemic-euglycemic clamp, compared with only 
a 4-fold suppression after 32 weeks of a HFD ( Fig. 2E ). 
Likewise, ketogenesis was incremented by 7-fold between 
the fasted and fed state in control mice, but it was barely 
responsive to nutritional state in 32-week HFD mice ( Fig. 
2F ). These data indicate that ketogenesis occurs constitu-
tively during hepatic insulin resistance but that severe in-
sulin resistance (i.e., 32 weeks of HFD) blunts maximum 
ketogenesis. However, this modestly impaired fasting keto-
genesis was still a 2-fold higher fl ux for acetyl-CoA than 
TCA cycle oxidation, indicating that   -oxidation remained 
in excess of respiratory requirements. 
 Progressing hepatic insulin resistance and steatosis 
dysregulates mitochondrial respiration 
 Because isotopomer analysis indicated increased he-
patic oxidative fl ux, we determined whether fatty liver and 
gluconeogenesis were elevated after 16 and 32 weeks of 
HFD ( Fig. 1E, F ). Elevated gluconeogenesis was due solely 
to increased fl ux from TCA cycle intermediates, with no 
change in gluconeogenesis from glycerol (supplementary 
Table VI). Furthermore, carbon-13 NMR isotopomer anal-
ysis (supplementary Tables IV–VI) of plasma glucose re-
vealed that absolute anaplerotic/cataplerotic fl ux of the 
TCA cycle was elevated by roughly 50% after 16 ( P  < 0.02) 
and 32 ( P  < 0.02) weeks of HFD ( Fig. 1G and supplemen-
tary Table VI). Although  Pc expression was not affected by 
HFD ( Table 2 ), this enzyme is mainly regulated through 
allosteric interaction with acetyl-CoA ( 58 ), consistent with 
elevated TCA cycle activity and increased hepatic acetyl-
carnitine ( Table 3 ).  Thus, increased TCA cycle anaplerosis 
contributed to elevated gluconeogenesis during impaired 
insulin action, perhaps by metabolic or substrate level acti-
vation of PC. 
 In vivo hepatic TCA cycle activity is induced by 
chronic HFD 
 Because oxidative and respiratory dysfunction has been 
implicated in hepatic insulin resistance, we examined he-
patic lipid oxidation and oxidative TCA cycle fl ux in HFD 
mice. Mice on HFD had high levels of short-chain acylcar-
nitines ( Table 3 ), which was most striking after 32 weeks 
for C2 (4-fold), C3 (6-fold), and C4 (3-fold). This fi nding 
is consistent with elevated   -oxidation previously described 
in insulin-resistant muscle ( 59 ). The TCA cycle oxidizes 
acetyl-CoA produced by   -oxidation and provides reduc-
ing equivalents (NADH and FADH 2 ) required for respi-
ration and redox coupled reactions. Carbon-13 NMR 
isotopomer analysis of plasma glucose indicated that the 
rate of gluconeogenesis relative to the rate of TCA cycle 
turnover was reduced after 16 weeks of HFD ( Fig. 2A and 
supplementary Table V).  This fi nding, combined with a 
higher absolute rate of gluconeogenesis ( Fig. 1E, F ) indi-
cated elevated hepatic TCA cycle fl ux. Integrated analysis 
of  13 C and  2 H plasma glucose isotopomers (supplementary 
Tables I–VI) confi rmed a 90% ( P  = 0.001) higher oxidative 
fl ux through the hepatic TCA cycle at 16 weeks, which per-
sisted at 32 weeks ( P  = 0.03 ) of HFD ( Fig. 2B ). To further 
confi rm elevated fat oxidation, we examined the rate of 
[1- 14 C]palmitate oxidation in liver homogenates after 16 
weeks of HFD. This experiment corroborated in vivo isoto-
pomer analysis, indicated by a 2-fold increase in  14 C incor-
poration into acid soluble intermediates ( P < 0.05) and a 
trend for increased  14 CO 2 ( P = 0.1) production ( Fig. 2C ). 
 TABLE 3. Hepatic acylcarnitine levels in overnight-fasted mice on a high-fat diet 
8 Weeks 16 Weeks 32 Weeks
Control Diet HFD  P Control Diet HFD  P Control Diet HFD  P 
Free carnitine 1337 ± 91 1680 ± 260 0.17 1555 ± 65 1374 ± 144 0.13 1345 ± 223 1384 ± 151 0.44
 C2 5.33 ± 1.4 6.74 ± 1.2 0.22 8.67 ± 1.2 13.2 ± 3.6 0.15 6.52 ± 1.7 26.5 ± 10 0.05
 C3 3.75 ± 0.69 12.3 ± 5.1 0.07 8.93 ± 2.1 11.5 ± 4.05 0.29 2.16 ± 0.40 12.8 ± 2.9 0.006
 C4 2.99 ± 1.0 2.79 ± 0.77 0.43 1.43 ± 0.18 4.23 ± 1.9 0.10 3.95 ± 0.66 12.0 ± 3.0 0.02
 C5 0.25 ± 0.06 0.24 ± 0.04 0.43 0.28 ± 0.05 0.37 ± 0.06 0.29 1.37 ± 0.18 2.14 ± 0.23 0.01
 C14 0.08 ± 0.02 0.04 ± 0.01 0.06 0.05 ± 0.01 0.05 ± 0.01 0.45 0.04 ± 0.004 0.06 ± 0.01 0.07
 C16 0.49 ± 0.06 0.68 ± 0.2 0.20 0.34 ± 0.06 0.52 ± 0.12 0.18 0.52 ± 0.05 0.75 ± 0.1 0.04
Acylcarnitine (nmol/g protein) in liver. Data are represented as the mean ± SE (n = 6–8).
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elevated respiration, the RCR was lower after 32 weeks of 
HFD with palmitoylcarnitine as a substrate, suggesting im-
paired coupling of oxidative metabolism and ATP synthe-
sis (supplementary Table VII and  Fig. 2G ), and consistent 
with elevated expression of UCP2 ( Table 2 ). Similar trends 
were obtained with succinate/rotenone and glutamate/
malate (supplementary Table VII). Despite altered mito-
chondrial respiration, transmission electron microscopy 
did not identify morphologic defects, though mitochon-
dria from HFD mice tended to be smaller (supplementary 
Fig. I-D). The data indicate that progressing insulin resis-
tance is accompanied by elevated mitochondrial content 
hepatic insulin resistance altered isolated mitochondrial 
function throughout 32 weeks of HFD. Quantifi cation of 
mitochondrial DNA indicated elevated mitochondrial 
content in mice following 16 and 32 weeks on HFD rela-
tive to their age-matched controls ( Fig. 2H ). Isolated 
mitochondria oxidizing palmitoylcarnitine/malate during 
ADP-stimulated (state 3) and ADP-depleted (state 4) con-
ditions tended to have increased O 2 consumption after 16 
weeks of HFD and was markedly elevated after 32 weeks of 
HFD ( Fig. 2G ). These data are consistent with recent fi nd-
ings of upregulated hepatic mitochondrial respiration in 
HFD mice ( 24, 25 ) and humans with diabetes ( 27 ). Despite 
 Fig.  2. Hepatic mitochondrial metabolism is elevated in HFD mice. (A) Carbon-13 isotopomer analysis of plasma glucose was used to 
evaluate hepatic fl uxes relative to the TCA cycle after administration of [U- 13 C]propionate as described by Landau et al. ( 46 ) and adapted 
to NMR analysis ( 48 ) for determination of absolute fl ux ( 41 ). See supplementary Table IV for isotopomer data. (B) In vivo hepatic mito-
chondrial TCA cycle fl ux in overnight-fasted mice (awake and unrestrained). (C) Oxidation of [1- 14 C]palmitate in liver homogenates from 
16-week-old HFD mice. (D) Determination of in vivo ketogenic fl ux by apparent turnover of [3,4- 13 C 2 ]acetoacetate and [U- 
13 C 4 ]  -
hydroxybutyrate. (E, F) Suppression of fasting in vivo ketogenesis by (E) euglycemic hyperinsulinemic clamp or (F) feeding. (G) Mitochon-
drial DNA content determined by real-time quantitative PCR. (H) Isolated mitochondrial respiration measured as O 2 consumption with 
palmitoylcarnitine/malate as substrate in the presence of no ADP (State 2), ADP (State 3), or ADP depletion (State 4) expressed as % dif-
ference from their respective age-matched control average (see supplementary Table VII for raw data). Data are presented as the mean ± 
SE (n = 4–8). 
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cycle function for substrate or energetic potential. Gluco-
neogenesis from TCA cycle precursors was elevated, and 
there was a marked increase in fl ux through the anaple-
rotic/cataplerotic pathways of the TCA cycle. Although 
impaired insulin action during a HFD did not result in el-
evated PEPCK expression, this appears to be a common 
feature of HFD rodents ( 57 ). However, G6Pase expression 
was increased, and although PC expression was normal, 
elevated acetylcarnitine was consistent with the known 
posttranslational activation of PC by acetyl-CoA and fat 
oxidation ( 58 ). This is also teleologically consistent with 
the known metabolic activation of gluconeogenesis by oxi-
dative metabolism via  (i) formation of citrate by the TCA 
cycle, which allosterically inhibits glycolysis;  (ii) generation 
of cofactors (NADH and ATP) required for the reactions 
of gluconeogenesis; and  (iii) allosteric activation of PC by 
acetyl-CoA ( 58, 61 ). In agreement with these metabolic 
factors, the anaplerotic and oxidative fl uxes of the TCA 
cycle are reciprocally regulated in the liver of humans and 
mice ( 47, 62 ), suggesting that the induction of gluconeo-
genesis by impaired insulin action may stimulate oxidative 
metabolism. 
 Elevated TCA cycle fl ux is also likely incited by dysfunc-
tional mitochondrial respiration, especially during later 
stages of hepatic insulin resistance. Loss of insulin action 
is reported to degrade respiratory complexes 1 and 3 via 
downstream targets of Foxo1 ( 22 ), which might account 
for impaired mitochondrial function during a HFD. The al-
terations in isolated mitochondrial function observed here 
are generally consistent with previous reports of increased 
expression of respiratory proteins, oxidative capacity, uncou-
pled respiration, and impaired membrane potential in simi-
lar mouse models of insulin resistance ( 18, 24, 25 ), and 
with impaired hepatic ATP synthesis ( 3, 20 ) in humans 
with insulin resistance. Mitochondrial dysfunction is some-
what paradoxical in the setting of increased gluconeogen-
esis, as this pathway traverses the mitochondria and requires 
mitochondrial-derived NADH and ATP for a number of its 
steps. However, elevated TCA cycle fl ux partially resolves 
the paradox by supplying increased NADH/FADH 2 as com-
pensation for dysfunctional respiration and by providing 
increased cataplerotic substrates to support overactive syn-
thetic pathways. Although we found elevated TCA cycle func-
tion (16 weeks) to predate respiratory dysfunction in isolated 
mitochondria (32 weeks), it is possible that the latter was 
present even earlier, as reported in other studies ( 18, 24, 25 ) 
but not detected in our particular experimental protocol 
(i.e., fasting state, mitochondrial isolation procedure, etc.). 
 The molecular mechanism responsible for increased 
TCA cycle metabolism was not completely evident from 
analysis of gene expression. PGC-1  was mildly induced at 
16 weeks, which is consistent with loss of Akt and Foxo1 
phosphorylation and with our previous fi nding that PGC-
1  is required for optimal TCA cycle function ( 63 ). How-
ever, it was not elevated after 32 weeks of HFD, and other 
regulators or metabolic enzymes of fat oxidation were ac-
tually decreased, which is qualitatively similar to other 
fi ndings in HFD mice ( 64 ). Downregulated fat oxidation 
during severe insulin resistance has been linked to impaired 
and increased in vitro respiration but that mitochondrial 
O 2 consumption and ATP synthesis are ineffi ciently 
coupled. These results are consistent with recent studies 
( 18, 24, 25, 27 ) and suggest that elevated in vivo hepatic 
TCA cycle fl ux during insulin resistance may be re-
quired to compensate for reduced mitochondrial cou-
pling effi ciency. 
 Induction of oxidative metabolism marks the onset 
of oxidative stress and infl ammation during hepatic 
insulin resistance 
 ROS production is a collateral consequence of mito-
chondrial respiration ( 60 ). Inasmuch as TCA cycle fl ux is 
a principal source of electrons for the respiratory chain, 
we examined whether the onset of oxidative stress and in-
fl ammation corresponded to the induction of TCA cycle 
function. Fasting liver ceramide content, a lipid metabo-
lite that promotes both insulin resistance and infl amma-
tion ( 4 ), was elevated after 32 weeks of HFD ( Fig. 3A ). 
Superoxide dismutase activity in liver homogenates was 
higher in 32-week HFD mice ( Fig. 3B ), indicating height-
ened antioxidant response. Increased hepatic protein car-
bonylation after 16 weeks ( Fig. 3C ) and thiobarbituric acid 
reactive substance (TBARS) after 32 weeks ( Fig. 3D ) con-
fi rmed the onset ROS-mediated oxidative damage. It is not 
clear why protein carbonylation was evident before other 
markers of oxidative stress, but it might be due to transient 
factors, such as fasting status. Nonetheless, hepatocellular 
damage at 16 weeks was consistent with elevated hepatic 
mRNA levels of  IL6 ,  Tnf  , and  Cox-2/Ptgs2 ( Fig. 3E–G ), 
which might be an infl ammatory response to oxidative 
damage. Histologic evidence of liver infl ammation did not 
appear until 32 weeks of HFD, as indicated by lymphocytic 
infi ltration in HE-stained sections of liver ( Fig. 3H ). In 
contrast, circulating interlukins (supplementary Fig. I-E) 
were increased by 8 weeks, in agreement with the rapid 
affect of obesity on adipose infl ammation ( 14, 16 ). Over-
all, the induction of oxidative stress and infl ammation 
during hepatic insulin resistance is consistent with previ-
ous data ( 5, 8–12, 17, 18 ). The common timing is consis-
tent with ROS production originating with elevated TCA 
cycle fl ux and a concomitant electron load to a dysfunc-
tional respiratory chain. 
 DISCUSSION 
 The putative role of dysregulated intracellular lipid ca-
tabolism in the mechanism of insulin resistance and NA-
FLD led us to investigate mitochondrial TCA cycle 
metabolism in the liver of mice developing hepatic insulin 
resistance and fatty liver. The fi ndings of this study indi-
cate that lipid accumulation and loss of insulin action re-
sult in elevated oxidative and anaplerotic pathways of the 
hepatic TCA cycle. The initial rise in mitochondrial TCA 
cycle metabolism coincided precisely with the loss of 
Foxo1 phosphorylation. Thus, one potential metabolic 
mechanism by which TCA cycle function is elevated dur-
ing insulin resistance follows from the dysregulation of 
insulin-regulated biosynthetic pathways that require TCA 
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 Elevated fasting TCA cycle fl ux during severe insulin re-
sistance appears to contradict impaired fasting ketogenesis 
and the suppression of some   -oxidation genes. We sus-
pect that the canonical autoregulation of TCA cycle func-
tion by cellular energy status ( 30 ) is a dominant factor that 
induces TCA cycle fl ux under conditions of respiratory un-
coupling and increased biosynthetic demand, even in the 
setting of impaired ketogenesis. In this regard, it is impor-
tant to note that fasting   -oxidation greatly exceeds hepa-
tocellular energy requirements, with excess acetyl-CoA 
shunted to ketogenesis rather than being oxidized in the 
TCA cycle ( 31 ). In other words, the TCA cycle oxidizes the 
acetyl-CoA required for cellular energy homeostasis, so 
fasting ketogenesis is much more pliable to the effects 
SIRT1 activity and deactivated PGC-1  (but not reduced 
expression) ( 23 ). Impaired SIRT3 activity during hepatic 
insulin resistance may also reduce the activity of enzymes 
of lipid oxidation ( 29 ). In agreement with those data, we 
found that fasting ketogenesis was mildly suppressed at 32 
weeks of HFD and markedly suppressed in more severely 
insulin-resistant models ( 39 ). Thus maximal   -oxidation 
may be blunted during severe insulin resistance (32 weeks) 
compared with a moderate condition (16 weeks) where it 
is actually increased. Despite blunted fasting ketogenesis, 
its suppression by feeding and clamp was diminished, sug-
gesting constitutively active   -oxidation in the prandial 
state and loss of the normal metabolic fl exibility of hepatic 
fat oxidation. 
 Fig.  3. Markers of oxidative stress and infl ammation are elevated with the same timing as increased oxidative metabolism in the liver of 
HFD mice. (A) Total ceramide levels in the liver measured by LC-MS/MS analysis; (B) superoxide dismutase activity measured in liver 
homogenates; (C) carbonylation of proteins in lysates from crude liver mitochondria with Coomasie-stained gel as loading control; (D) 
lipid peroxidation assessed by analysis of TBARS; (E–H) relative gene expression analysis of (E)  Il6, (F)  Tnf a , and (G)  Ptgs2 , and (H) 
Hematoxylin-stained liver sections with arrows indicating macrophage infi ltration (original magnifi cation ×20; n = 2) in overnight-fasted 
mice fed either a control or high-fat diet for 8, 16, and 32 weeks. Data are presented as the mean ± SE (n = 6–8) unless otherwise noted. 
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in combination with the mouse data, suggest that the col-
lateral oxidative stress caused by this process may be im-
portant in progression of NAFLD. This is a well-covered 
topic within the fi eld of NAFLD, with most attention is-
sued to the role of respiratory chain defects in ROS pro-
duction. The present data highlight regulatory defects of 
TCA cycle function as a source of increased electron depo-
sition to a ROS-prone respiratory chain. 
 In conclusion, the metabolic events during the progres-
sion of diet-induced hepatic insulin proceed from  i ) meta-
bolic overload of lipid and initiation of hepatic insulin 
resistance;  ii ) loss of insulin-mediated suppression of glu-
coneogenesis and mitochondrial TCA cycle metabolism; 
and  iii ) impaired mitochondrial effi ciency, oxidative stress, 
infl ammation, and hepatocellular damage associated with 
chronic insulin resistance and fatty liver disease. The 
causal factors linking these processes remain to be identi-
fi ed, but induction of the mitochondrial TCA cycle ap-
pears to metabolically enable, if not instigate, mitochondrial 
dysfunction and oxidative stress during hepatic insulin re-
sistance.  
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of dysregulated   -oxidation. To put this in perspective, de-
spite a 30% reduction in ketogenesis and a 40% increase 
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two-thirds of their acetyl-CoA via ketogenesis, and acetyl-
carnitine is actually elevated. We deduce from these data 
that impaired   -oxidation can occur with severe insulin 
resistance, but under most circumstances, oxidative fl ux in 
the hepatic TCA cycle is not at risk of being limited. 
 Elevated TCA cycle fl ux during insulin resistance indi-
cates a marked increase in electron deposition into the 
respiratory chain, which might be an important element 
in the known link between oxidative stress, infl ammation, 
and hepatic insulin resistance ( 5, 9 ). The simultaneous ap-
pearance of impaired AKT phosphorylation, infl ammatory 
cytokine expression, and increased oxidative fl ux may 
indicate a common metabolic etiology. Coordinately in-
creased TCA cycle fl ux and impaired mitochondrial re-
spiratory effi ciency is consistent with elevated oxygen 
demand, which has been suggested to potentiate hypoxia-
related ROS production and cell damage in a similar 
model ( 18 ). The production of ROS associated with ele-
vated fat oxidation causes insulin resistance by activation 
of NF-  B- and/or JNK-mediated IRS phosphorylation ( 12, 
16 ), a process which can be ameliorated by suppressing 
  -oxidation in cell systems ( 13 ). An isotopomer study car-
ried out in liver cells treated with palmitate also specifi -
cally demonstrated that elevated TCA cycle function was 
suffi cient to mediate cell damage and lipoapoptosis ( 65 ). 
Such cellular stresses are known to recruit proinfl amma-
tory macrophages ( 14 ), and this process appears to be re-
quired for diet-induced hepatic insulin resistance ( 15 ). 
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study, it is not surprising that both elevated ( 8 ) and re-
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NAFLD. Positron emission tomography studies indicated 
that obese humans have increased total   -oxidation (keto-
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the TCA cycle had increased anaplerotic and oxidative 
fl uxes that correlated with the degree of liver fat ( 68 ). 
These data indicate that limitations in fat oxidation are 
unlikely to contribute to hepatic lipid accumulation, but 
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